Key points are not available for this paper at this time.
HSPCs. This resulted in at least six loci tolerant to transgene insertion, low transcriptome disturbances, and three loci showing myeloid immune branch-specific regulation. Thus, our approach produced a catalog of candidate GSHs suitable for therapeutic transgenesis in human cells.
Quezada‐Ramírez et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: